Zytiga Approved For Use in Germany

Zytiga has been approved for use in Germany by the drug benefit assessor.

Decisions by Germany’s drug benefit assessor, IQWiG, to recommend novel prostate cancer treatment Zytiga and reject me-too diabetes treatment Trajenta may allay confusion over just how well the country’s new added value assessment process is working.